Walgreens Boots Alliance beat Wall Street earnings expectations Thursday, sending shares up about 3% in early trading.

Here’s what Walgreens reported for its fiscal second quarter of 2020 compared with what Wall Street was expecting, based on a survey of analysts by Refinitiv:

• Earnings per share: $1.52 adjusted, vs. $1.46 expected
• Revenue: $35.82 billion, vs. $35.27 billion expected

The global pharmacy chain’s second quarter ended before the number of COVID-19 cases in the U.S. rose significantly and changed customers’ shopping patterns. In recent weeks, however, it has been one of the retailers where customers have gone to stock up on over-the-counter medications, prescriptions and items, such as cleaning supplies and disposable gloves.

Before the pandemic, Walgreens said it was on track with its 2020 forecast to have roughly flat growth. It said the impact of the outbreak is unclear, and it will provide updates in its next earnings report.

In the second quarter ended Feb. 29, net income fell to $946 million, or $1.07 per share, from $1.16 billion, or $1.24 per share, a year earlier.

After adjustments, Walgreens earned $1.52 per share, which was more than the $1.46 per share analysts were expecting, according to Refinitiv. 

Walgreens said revenue grew to $35.82 billion, from $34.53 billion last year, and higher than the $35.27 billion analysts expected.

In the past week, Walgreens has added new ways for U.S. customers to buy essential items while socially distancing. Customers can now buy more than 60 popular items, such as cleaning supplies, cough and cold medications and formula, at its more than 7,300 pharmacy drive-thrus in the U.S. It also has a partnership with Postmates to make contactless deliveries to customers’ homes. 

Its competitor, CVS Health, has also seen a surge of demand because of the pandemic and plans to fill 50,000 jobs for store associates, home delivery drivers, distribution center employees and customer service professionals.

This story is developing and will be updated.